RecruitingNot ApplicableNCT06700304

CAN-PRIME: Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

CAN-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices

Sponsor

Neuralink Corp

Enrollment

6 participants

Start Date

Nov 20, 2024

Study Type

INTERVENTIONAL

Conditions

Quadriplegia Spinal Cord Injury Amyotrophic Lateral Sclerosis(ALS)Cervical Spinal Cord Injury Tetraplegia/Tetraparesis Quadriplegia/Tetraplegia Spinal Cord Injury (Quadraplegia)

Summary

The CAN-PRIME Study is to test the safety and functionality of Neuralink's N1 Implant and R1 Robot in people who have difficulty moving their arms and legs (tetraparesis or tetraplegia). The N1 Implant is a small, wireless device placed in the skull. It connects to tiny threads inserted into the brain by the R1 Robot, which is a machine designed to carefully place these threads. This study will help researchers learn how well the implant and robot work and if they are safe for use.

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called N1 Implant and a medical device called R1 Robot for people with amyotrophic lateral sclerosis(als), cervical spinal cord injury, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.